Objective To investigate the association between sodium-glucose cotransporter-2 (SGLT-2) inhibitor use and risk of all cause mortality among patients with heart failure with reduced ejection fraction ...

Background and Objective: Mobile Integrated Health (MIH) interventions enable community paramedics to perform structured assessments, physical exams, and medication reconciliation, provide disease ...

"We found that beta blockers led to slightly higher levels of depression symptoms in patients who had had a heart attack but were not suffering from heart failure," said study lead author Philip ...

Objective To test the therapeutic potential of acupuncture for life-threatening diseases such as CHF. Methods 17 stable patients with CHF (New York Heart Association class II–III, ejection fraction ...

CINCINNATI (WKRC) — A medical team at The Christ Hospital Heart and Vascular Center has successfully implanted a new type of artificial heart in a patient with heart failure, marking a ...

Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS ...

The first study of COVID-19 vaccine effectiveness in a large population of adult heart-failure patients suggests that vaccinated participants are 82% more likely to live longer than their unvaccinated ...

Systolic congestive heart failure, or systolic heart failure, is a type of heart failure that involves the left side of the heart. As the left side of the heart begins losing some function, it ...

The combination of heart failure and anemia can lead to decreased exercise tolerance, increased fatigue, and impaired quality of life. Anemia in heart failure patients may be caused by various factors ...

Symptoms of left-sided heart failure can include chest pain, fatigue, shortness of breath, and leg swelling. They can be similar to other medical conditions and, early on, even go unnoticed. When the ...

The findings point to the possibility of developing such immunotherapies for heart failure in patients who have experienced a heart attack or other injury. A new study from Washington University ...